Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Instituto do Cancer do Estado de São Paulo
Hoffmann-La Roche
Merck Sharp & Dohme LLC
EpicentRx, Inc.
Charite University, Berlin, Germany
Hoffmann-La Roche